# FDA Inspection 1239725 - Granules India Limited - April 12, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/granules-india-limited/df9d1947-0f55-4bf9-b9de-9bad5c74f9e5
Source feed: FDA_Inspections

> FDA Inspection 1239725 for Granules India Limited on April 12, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1239725
- Company Name: Granules India Limited
- Inspection Date: 2024-04-12
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1203725 - 2020-01-16](https://www.globalkeysolutions.net/records/fda_inspections/granules-india-limited/40b583a4-985c-4384-901f-b1d23cfc31ae)

Company: https://www.globalkeysolutions.net/companies/granules-india-limited/fe3d9552-4085-4a48-af38-ad27759c2608

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c